Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?

Introduction Long-acting muscarinic antagonists (LAMA) or beta-2 agonists (LABA) have been recommended for symptom control in group A COPD patients as a first-line bronchodilator treatment in GOLD guidelines. However, there is no mention of priority/superiority between the two treatment options. We...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of clinical pharmacology 2024-06, Vol.80 (6), p.847-853
Hauptverfasser:	Turan, Onur, Ogan, Nalan, Bozkus, Fulsen, Sarıoğlu, Nurhan, Turan, Pakize Ayşe, Satıcı, Celal
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetylcholine receptors (muscarinic) Agonists Antagonists Biomedical and Life Sciences Biomedicine Bronchodilators Chronic obstructive pulmonary disease Emphysema Pharmacology/Toxicology Phenotypes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!